Release Date: 27/04/23 12:28 Summary: Quarterly Cash Flow Report Price Sensitive: Yes Download Document 222.14KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%